Indonesia Healthcare and Pharmaceuticals Sector Report 2016/2017

  • ID: 4330131
  • Report
  • Region: Indonesia
  • 75 pages
  • EMIS, An ISI Emerging Markets Group Company
1 of 5

FEATURED COMPANIES

  • PT Kalbe Farma Tbk
  • PT Merck Tbk
  • PT Prodia Widyahusada Tbk
  • MORE

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Indonesia. We present in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Indonesia
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Indonesia
  • Crystallise the forces both driving and restraining this sector in Indonesia
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Indonesia
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • PT Kalbe Farma Tbk
  • PT Merck Tbk
  • PT Prodia Widyahusada Tbk
  • MORE

01 EXECUTIVE SUMMARY

  • Sector in Numbers 2015
  • Sector Overview
  • Sector Snapshot
  • Sector Outlook
  • Subsector Outlook
  • Driving Forces
  • Restraining Forces

02 SECTOR IN FOCUS

  • Main Economic Indicators
  • Main Sector Indicators
  • Health Profile
  • Healthcare Expenditure
  • Tax Revenues
  • Infrastructure Spending
  • Logistics Costs
  • Global Positioning – Healthcare

03 COMPETITIVE LANDSCAPE

  • Highlights
  • Top Companies
  • Top M&A Deals
  • M&A Activity, 2015 – March 2017

04 COMPANIES IN FOCUS

  • PT Siloam International Hospitals Tbk
  • PT Mitra Keluarga Karyasehat Tbk
  • PT Kalbe Farma Tbk
  • PT Indofarma (Persero) Tbk
  • PT Merck Tbk
  • PT Prodia Widyahusada Tbk

05 REGULATORY ENVIRONMENT
Government Policy

06 HEALTHCARE SERVICES

  • Highlights
  • Main Events
  • Focus Point – National Health Insurance Participants
  • Healthcare Services Demand
  • Healthcare Services Supply

07 MEDICAL DEVICES

  • Highlights
  • External Trade
  • Consumables
  • Diagnostic Imaging
  • Patient Aids

08 PHARMACEUTICALS

  • Highlights
  • External Trade
  • Prescription Drugs
  • OTC Drugs
  • Health Supplements
  • Traditional and Complementary Medicine

09 RETAIL CHANNELS
Pharmaceuticals Distribution

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • PT Kalbe Farma Tbk
  • PT Merck Tbk
  • PT Prodia Widyahusada Tbk
  • MORE
Indonesia's healthcare and pharmaceuticals industry is one of the least developed in ASEAN and Indonesia has low scores on most metrics – including number of hospitals and beds per 10,000 population and healthcare expenditure per capita. These limitations have also made Indonesia one of the biggest source countries for healthcare tourism in the region, as wealthier Indonesians seek to travel to other countries in the region to obtain advanced treatments inaccessible in their own country.

The Indonesian government has, in recent years, focused on expanding healthcare coverage and developing the healthcare infrastructure. The low-base effect and this concerted policy effort have made the Indonesian healthcare and pharmaceuticals sector one of the fastest-growing in the region.
Note: Product cover images may vary from those shown
5 of 5
  • PT Siloam International Hospitals Tbk
  • PT Mitra Keluarga Karyasehat Tbk
  • PT Kalbe Farma Tbk
  • PT Indofarma (Persero) Tbk
  • PT Merck Tbk
  • PT Prodia Widyahusada Tbk
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll